Compounds > cyclic-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine
Page last updated: 2024-09-03

cyclic-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine and Lung Diseases

cyclic-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine has been researched along with Lung Diseases in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bailey, KW; Sidwell, RW; Smee, DF1

Other Studies

1 other study(ies) available for cyclic-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine and Lung Diseases

ArticleYear
Comparative effects of cidofovir and cyclic HPMPC on lethal cowpox and vaccinia virus respiratory infections in mice.
    Chemotherapy, 2003, Volume: 49, Issue:3

    Topics: Administration, Intranasal; Animals; Antiviral Agents; Cidofovir; Cowpox; Cytosine; Female; Infusions, Parenteral; Liver; Lung Diseases; Mice; Mice, Inbred BALB C; Organophosphonates; Organophosphorus Compounds; Vaccinia

2003